Atlas Trials

Efficacy and Safety of Terlipressin With Albumin Versus Midodrine With Albumin Versus Albumin Alone in Prevention of Paracentesis Induced Circulatory Dysfunction in Cirrhosis

Clinical trial NCT03144713 · COMPLETED

Trial details

NCT number
NCT03144713
Sponsor
Institute of Liver and Biliary Sciences, India
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Cirrhosis
Start date
2017-05-28
Primary completion
2018-04-30
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.